Harry Bartelink

Harry Bartelink

Netherlands Cancer Institute - Amsterdam / Netherlands
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 4963190
Nederlands Kanker Instituut
person_outline Harry Bartelink's MOST POPULAR ARTICLES
1-) A gene-expression signature as a predictor of survival in breast cancer - MJ Van De Vijver, YD He, LJ Van\\\\\\\\\\\\\\\'t Veer, H Dai, AAM Hart, DW Voskuil, ...
2-) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial - JA Van Dongen, AC Voogd, IS Fentiman, C Legrand, RJ Sylvester, ...
3-) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer - C Schaake-Koning, W Van den Bogaert, O Dalesio, J Festen, ...
4-) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the …H Bartelink, F Roelofsen, F Eschwege, P Rougier, JF Bosset, ...Journal of clinical oncology 15 (5), 2040-2049, 199715481997
5-) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost …H Bartelink, JC Horiot, PM Poortmans, H Struikmans, W Van den Bogaert, ...Journal of Clinical Oncology 25 (22), 3259-3265, 200713462007